Publication:
Combined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiency

dc.contributor.authorPhonchanan Pakparnichen_US
dc.contributor.authorSirapapha Sudsumriten_US
dc.contributor.authorMallika Imwongen_US
dc.contributor.authorTeeraporn Suteewongen_US
dc.contributor.authorKamonwan Chamchoyen_US
dc.contributor.authorDanaya Pakotipraphaen_US
dc.contributor.authorUbolsree Leartsakulpanichen_US
dc.contributor.authorUsa Boonyuenen_US
dc.contributor.otherFaculty of Tropical Medicine, Mahidol Universityen_US
dc.contributor.otherChulabhorn Royal Academyen_US
dc.contributor.otherKing Mongkut's Institute of Technology Ladkrabangen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThailand National Center for Genetic Engineering and Biotechnologyen_US
dc.date.accessioned2022-08-04T11:37:28Z
dc.date.available2022-08-04T11:37:28Z
dc.date.issued2021-12-01en_US
dc.description.abstractGlucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in humans, affecting ~ 500 million worldwide. A detailed study of the structural stability and catalytic activity of G6PD variants is required to understand how different mutations cause varying degrees of enzyme deficiency, reflecting the response of G6PD variants to oxidative stress. Furthermore, for G6PD double variants, investigating how two mutations jointly cause severe enzyme deficiency is important. Here, we characterized the functional and structural properties of nine G6PD variants: G6PD Gaohe, G6PD Mahidol, G6PD Shoklo, G6PD Canton, G6PD Kaiping, G6PD Gaohe + Kaiping, G6PD Mahidol + Canton, G6PD Mahidol + Kaiping and G6PD Canton + Kaiping. All variants were less catalytically active and structurally stable than the wild type enzyme, with G6PD double mutations having a greater impact than single mutations. G6PD Shoklo and G6PD Canton + Kaiping were the least catalytically active single and double variants, respectively. The combined effects of two mutations were observed, with the Canton mutation reducing structural stability and the Kaiping mutation increasing it in the double mutations. Severe enzyme deficiency in the double mutants was mainly determined by the trade-off between protein stability and catalytic activity. Additionally, it was demonstrated that AG1, a G6PD activator, only marginally increased G6PD enzymatic activity and stability.en_US
dc.identifier.citationScientific Reports. Vol.11, No.1 (2021)en_US
dc.identifier.doi10.1038/s41598-021-03800-zen_US
dc.identifier.issn20452322en_US
dc.identifier.other2-s2.0-85121504620en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/79182
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121504620&origin=inwarden_US
dc.subjectMultidisciplinaryen_US
dc.titleCombined effects of double mutations on catalytic activity and structural stability contribute to clinical manifestations of glucose-6-phosphate dehydrogenase deficiencyen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121504620&origin=inwarden_US

Files

Collections